Billing, coding, and payment updates for 2022
November 16, 2021
Every clinical and anatomic pathology laboratory in America is affected by new Medicare and Medicaid coding and billing changes that take effect every year on Jan. 1. Next year is no exception, with new codes, revised codes, and deleted codes. Tune in and hear from one of our industry’s experts and prepare for the 2022 changes today.
Diana Voorhees, M.A., CLS, MT, SH, CLCP, CPCO
DV & Associates
Salt Lake City, Utah
Upon completion of this activity, participants should be able to:
The outreach webinars are applicable to community hospital laboratory administrators, managers, directors, pathologists, outreach coordinators, marketing representatives, and sales managers.
The following types of credit are offered for this event:
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for the State of California. This program has been approved for 1.0 contact hour.
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for Supervision/Administration, Quality Control/Quality Assurance, and Safety credit. This program has been approved for 1.0 contact hour.
1. Watch the video.
2. Complete the evaluation that will be sent to you after the program.
3. Generate and print your certificate(s).
Level of instruction for this program is intermediate.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Contact us: email@example.com